Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy

Stem Cell Res. 2023 Oct:72:103210. doi: 10.1016/j.scr.2023.103210. Epub 2023 Sep 21.

Abstract

Here we introduce the human induced pluripotent stem cell (hiPSC) line HIMRi001-A generated from cultured dermal fibroblasts of a 60-year-old male patient with a myofibrillar myopathy, carrying a heterozygous c.4984C > T [p.Q1662X] mutation in the filamin C (FLNC)-gene, via lentiviral expression of OCT4, SOX2, KLF4 and c-MYC. HIMRi001-A displays typical embryonic stem cell-like morphology, carries the c.4984C > T FLNC gene mutation, expressed several pluripotent stem cell makers, retained normal karyotype (46, XY) and holds the potential to differentiate in all three germ layers. We postulate that HIMRi001-A can be used for the elucidation of FLNC-associated pathomechanisms and for developing new therapeutic options.

Publication types

  • Case Reports

MeSH terms

  • Cell Differentiation / genetics
  • Fibroblasts / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Kruppel-Like Factor 4
  • Male
  • Middle Aged
  • Mutation
  • Pluripotent Stem Cells*

Substances

  • Kruppel-Like Factor 4